Pharmacology · MU Sofia

17. Pharmacological modulation of the cholinergic neurotransmission– levels and mechanisms.

Covers how acetylcholine signalling can be altered at each stage: synthesis, vesicular storage, release, receptor activation and enzymatic breakdown. Sections give examples such as hemicholinium-3, vesamicol and botulinum toxin, then muscarinic and nicotinic agonists and antagonists with their clinical effects. It closes with reversible and irreversible acetylcholinesterase inhibitors, including organophosphates, followed by recap questions.

Inside: 5 sections · 3 labelled pictures · 12 flashcards · 3 min

Topic 16 of 93 in the MU Sofia syllabus for Pharmacology (Dental Medicine, Year 3). The free AceMed note covers it in 5 sections, about 364 words (3 min of reading), with 12 flashcards.

In this note

  1. Pharmacological modulation of the cholinergic neurotransmission- levels and mechanisms.
  2. Mechanisms of Pharmacological Modulation
  3. Receptor Modulation
  4. Inhibition of Acetylcholine Degradation
  5. Recap Questions

Pharmacological modulation of the cholinergic neurotransmission- levels and mechanisms.

Cholinergic neurotransmission refers to the process by which acetylcholine (ACh) is released from nerve endings and interacts with cholinergic receptors to regulate various physiological functions. Pharmacological modulation of this system can occur at different stages, including synthesis, storage, release, receptor activation, and degradation.

Mechanisms of Pharmacological Modulation

1.1 Inhibition of Acetylcholine Synthesis

  • Mechanism: Blocks choline uptake, reducing ACh synthesis.
  • Example:
  • Hemicholinium-3: Competes with choline for uptake into the presynaptic neuron, decreasing ACh levels → reduced cholinergic transmission.

1.2 Inhibition of Vesicular Storage

  • Mechanism: Prevents ACh from being stored in synaptic vesicles.
  • Example:
  • Vesamicol: Inhibits vesicular ACh transporter (VAChT), reducing ACh available for release → weaker cholinergic signaling.

1.3 Inhibition of Acetylcholine Release

  • Mechanism: Prevents the release of ACh into the synaptic cleft.
  • Example:
  • Botulinum toxin (Botox): Cleaves SNARE proteins (SNAP-25, syntaxin, synaptobrevin), which are essential for vesicle fusion → prevents ACh release, leading to muscle relaxation and paralysis.

Receptor Modulation

2.1 Muscarinic Receptor Modulation

  • Muscarinic Agonists: Activate muscarinic receptors, mimicking ACh effects.
  • Example:
  • Pilocarpine: Stimulates M receptors, causing increased salivation, miosis (pupil constriction), and bronchoconstriction.
  • Muscarinic Antagonists: Block muscarinic receptors, preventing ACh action.
  • Examples:
  • Atropine, Scopolamine: Cause mydriasis (pupil dilation), decreased salivation, and bronchodilation (used in anesthesia and asthma).

2.2 Nicotinic Receptor Modulation

  • Nicotinic Agonists: Stimulate nicotinic receptors, enhancing neurotransmission.
  • Example:
  • Nicotine: Stimulates CNS nicotinic receptors, leading to increased neurotransmitter release and muscle contraction.
  • Nicotinic Antagonists: Block nicotinic receptors, causing muscle relaxation.
  • Examples:
  • Tubocurarine, Pancuronium: Block neuromuscular junction (NMJ) nicotinic receptors, preventing ACh action → muscle relaxation/paralysis (used in surgery).

Continue reading free

The whole note, all 5 sections, is free with an AceMed account, with its 12 flashcards. Premium adds flashcard recall, highlights and Ask AI.

Start freeAlready a member? Open the note